ReviewNature reviews. Rheumatology2019
The IL-23-IL-17 pathway as a therapeutic target in axial spondyloarthritis.
Joachim Sieper et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
75 papers cite itlatest 60 shown
this paperpooled ittrialcites it